Literature DB >> 34422560

The reinforced full-root technique for the Ross operation: surgical considerations and operative insights.

Markus Liebrich1, Efstratios I Charitos2, Christoph Dingemann1, Detlef Roser1, Joerg Seeburger1, Wolfgang Hemmer1, Vladimir Voth1.   

Abstract

BACKGROUND: Surgical treatment of young and middle-aged patients suffering from aortic valve disease remains an unresolved issue due to the limited durability of bioprosthetic heart valve replacements and the valve-related morbidity of patients with mechanical valve substitutes. Theoretically, the "living valve" principle of the Ross operation may represent a potentially viable solution to this dilemma. In this paper, we report on the surgical techniques of the Ross procedure and present long-term post-operative outcomes using the reinforced full-root technique.
METHODS: From 1995 to 2020, a total of 832 consecutive patients (mean age, 43.4±13.7 years; 617 males) underwent a Ross operation using the full-root technique. Patients were prospectively monitored with clinical and echocardiographic follow-up. Total follow-up was 9,046 patients-years and was 92% complete. Mean-follow-up was 10.9±6.9 years (range, 0-24.9 years).
RESULTS: Survival at twenty years was 92% (95% CI: 90-94%). Freedom from autograft or right ventricle to pulmonary artery connection reoperation at twenty years was 79% (95% CI: 74-85%). Eighty-nine pulmonary autograft reoperations had to be performed in eighty patients; salvage of the pulmonary autograft could be performed in forty-six of them. Fifty-seven patients required sixty-three reoperations on the right ventricle to pulmonary artery connection. Major cerebral bleeding occurred in one patient and neurological events in seventeen patients, respectively.
CONCLUSIONS: Over a follow-up interval of up to twenty-five years, the Ross operation with the reinforced full-root technique demonstrated excellent survival in young and middle-aged patients. The rate of pulmonary autograft and right ventricular outflow graft reoperations were low in this patient subset. Therefore, the Ross operation with the reinforced full-root technique represents an enduring and valid treatment option in young and middle-aged patients suffering from aortic valve disease. 2021 Annals of Cardiothoracic Surgery. All rights reserved.

Entities:  

Keywords:  Ross operation; follow-up; surgical technique

Year:  2021        PMID: 34422560      PMCID: PMC8339614          DOI: 10.21037/acs-2020-rp-22

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  17 in total

Review 1.  Guidelines for reporting mortality and morbidity after cardiac valve interventions.

Authors:  Cary W Akins; D Craig Miller; Marko I Turina; Nicholas T Kouchoukos; Eugene H Blackstone; Gary L Grunkemeier; Johanna J M Takkenberg; Tirone E David; Eric G Butchart; David H Adams; David M Shahian; Siegfried Hagl; John E Mayer; Bruce W Lytle
Journal:  Ann Thorac Surg       Date:  2008-04       Impact factor: 4.330

2.  Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.

Authors:  Michael J Mack; Martin B Leon; Vinod H Thourani; Raj Makkar; Susheel K Kodali; Mark Russo; Samir R Kapadia; S Chris Malaisrie; David J Cohen; Philippe Pibarot; Jonathon Leipsic; Rebecca T Hahn; Philipp Blanke; Mathew R Williams; James M McCabe; David L Brown; Vasilis Babaliaros; Scott Goldman; Wilson Y Szeto; Philippe Genereux; Ashish Pershad; Stuart J Pocock; Maria C Alu; John G Webb; Craig R Smith
Journal:  N Engl J Med       Date:  2019-03-16       Impact factor: 91.245

3.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  J Am Coll Cardiol       Date:  2014-03-03       Impact factor: 24.094

4.  Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium.

Authors:  Shigeyuki Ozaki; Isamu Kawase; Hiromasa Yamashita; Shin Uchida; Mikio Takatoh; Nagaki Kiyohara
Journal:  J Thorac Cardiovasc Surg       Date:  2018-02-15       Impact factor: 5.209

5.  Age-related reoperation rate after the Ross procedure: a report from the German Ross Registry.

Authors:  Doreen Richardt; Wolfgang Hemmer; Anton Moritz; Roland Hetzer; Armin Gorski; Ulrich F W Franke; Jürgen Hörer; Rüdiger Lange; Jörg S Sachweh; Arlindo Riso; Ali Dodge-Khatami; Michael Hübler; Efstratios I Charitos; Ulrich Stierle; Hans-Hinrich Sievers
Journal:  J Heart Valve Dis       Date:  2015-03

6.  Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.

Authors:  John D Puskas; Marc Gerdisch; Dennis Nichols; Lilibeth Fermin; Birger Rhenman; Divya Kapoor; Jack Copeland; Reed Quinn; G Chad Hughes; Hormoz Azar; Michael McGrath; Michael Wait; Bobby Kong; Tomas Martin; E Charles Douville; Steven Meyer; Jian Ye; W R Eric Jamieson; Lance Landvater; Robert Hagberg; Timothy Trotter; John Armitage; Jeffrey Askew; Kevin Accola; Paul Levy; David Duncan; Bobby Yanagawa; John Ely; Allen Graeve
Journal:  J Am Coll Cardiol       Date:  2018-06-19       Impact factor: 24.094

7.  Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk.

Authors:  Martijn W A van Geldorp; W R Eric Jamieson; A Pieter Kappetein; Jian Ye; Guy J Fradet; Marinus J C Eijkemans; Gary L Grunkemeier; Ad J J C Bogers; Johanna J M Takkenberg
Journal:  J Thorac Cardiovasc Surg       Date:  2009-02-25       Impact factor: 5.209

8.  Valve performance classification in 630 subcoronary Ross patients over 22 years.

Authors:  Hans-Hinrich Sievers; Ulrich Stierle; Michael Petersen; Stefan Klotz; Doreen Richardt; Michael Diwoky; Efstratios I Charitos
Journal:  J Thorac Cardiovasc Surg       Date:  2018-03-12       Impact factor: 5.209

9.  The David procedure for salvage of a failing autograft after the Ross operation.

Authors:  Markus Liebrich; Timo Weimar; Ioannis Tzanavaros; Detlef Roser; Kai-Nicolas Doll; Wolfgang B Hemmer
Journal:  Ann Thorac Surg       Date:  2014-10-03       Impact factor: 4.330

10.  The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue.

Authors:  John D Puskas; Joseph E Bavaria; Lars G Svensson; Eugene H Blackstone; Bartley Griffith; James S Gammie; David A Heimansohn; Jerzy Sadowski; Krzysztof Bartus; Douglas R Johnston; Jacek Rozanski; Todd Rosengart; Leonard N Girardi; Charles T Klodell; Mubashir A Mumtaz; Hiroo Takayama; Michael Halkos; Vaughn Starnes; Percy Boateng; Tomasz A Timek; William Ryan; Shuab Omer; Craig R Smith
Journal:  Eur J Cardiothorac Surg       Date:  2017-09-01       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.